AU2003288214A1 - Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient - Google Patents
Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredientInfo
- Publication number
- AU2003288214A1 AU2003288214A1 AU2003288214A AU2003288214A AU2003288214A1 AU 2003288214 A1 AU2003288214 A1 AU 2003288214A1 AU 2003288214 A AU2003288214 A AU 2003288214A AU 2003288214 A AU2003288214 A AU 2003288214A AU 2003288214 A1 AU2003288214 A1 AU 2003288214A1
- Authority
- AU
- Australia
- Prior art keywords
- pharmaceutical preparation
- preparation containing
- lipophilic liquid
- nasal pharmaceutical
- active lipophilic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Anesthesiology (AREA)
- Organic Chemistry (AREA)
- Otolaryngology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE10257180 | 2002-12-06 | ||
| DE10257180.5 | 2002-12-06 | ||
| PCT/EP2003/013591 WO2004052337A2 (en) | 2002-12-06 | 2003-12-02 | Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2003288214A1 true AU2003288214A1 (en) | 2004-06-30 |
Family
ID=32477447
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2003288214A Abandoned AU2003288214A1 (en) | 2002-12-06 | 2003-12-02 | Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2003288214A1 (en) |
| WO (1) | WO2004052337A2 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19709704C2 (en) * | 1997-03-10 | 1999-11-04 | Michael Georgieff | Use of a liquid preparation of xenon for intravenous administration when inducing and / or maintaining anesthesia |
| GB9913677D0 (en) * | 1999-06-11 | 1999-08-11 | Imperial College | Formulation |
| DE10045845A1 (en) * | 2000-09-14 | 2002-04-04 | Messer Griesheim Gmbh | Xenon as a medicine |
-
2003
- 2003-12-02 AU AU2003288214A patent/AU2003288214A1/en not_active Abandoned
- 2003-12-02 WO PCT/EP2003/013591 patent/WO2004052337A2/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2004052337A2 (en) | 2004-06-24 |
| WO2004052337A3 (en) | 2004-09-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL163866A0 (en) | 8-Azaprostaglandin derivative compounds and drugs containing the compounds s active ingredient | |
| IL164699A0 (en) | Diketohydrazine derivative compounds and drugs containing the compounds as the active ingredient | |
| HUP0700039A2 (en) | Use of cannabinoid drugs for the preparation of medicines for decreasing cell proliferation | |
| SI1608362T1 (en) | Stabilized pharmaceutical preparation comprising an amorphous active substance | |
| AU2001234114A1 (en) | Drugs containing combined active ingredients | |
| AU2002257582A1 (en) | Pharmaceutical formulation | |
| AU2001278772A1 (en) | Benzoic acid derivatives and drugs containing the same as the active ingredient | |
| EP1539156B8 (en) | Liquid dosage forms of acid labile drugs | |
| AU2003243439A1 (en) | Medical device for intra-lumenal delivery of pharmaceutical agents | |
| AU2001277738A1 (en) | Piperidine derivatives and drugs containing these derivatives as the active ingredient | |
| AU2003238039A1 (en) | Nasal peptide pharmaceutical formulation | |
| AU2001267887A1 (en) | Medicinal components comprising human parathyroid hormone and medicinal compositions for nasal administration containing the components | |
| AU2002361473A1 (en) | Unit for delivering a single dosage of a liquid medicine | |
| AU2001260089A1 (en) | Pharmaceutical compositions comprising desglymidodrine as an active drug substance | |
| AU2003288214A1 (en) | Nasal pharmaceutical preparation containing an active lipophilic liquid or gaseous ingredient | |
| AU2003203233A1 (en) | N-substituted sulfonamide derivatives and preventive or therapeutic drugs for diabetes containing the same | |
| AU2002212863A1 (en) | Stable pharmaceutical form of an anticancer drug | |
| AU2001274236A1 (en) | Dry-powder pharmaceutical formulation for inhalation comprising alpha4-intergrinantagonist | |
| AU2002333235A1 (en) | Pharmaceutical formulation containing an LTB4 antagonist | |
| AU2002363776A1 (en) | Carboxylic acid derivative compounds and drugs containing the same as the active ingredient | |
| IL161768A0 (en) | Carboxylic acid derivative compounds and drugs containing the same as the active ingredient | |
| GB0201607D0 (en) | Formulation for the administration of medicinal substances | |
| AU2001295884A1 (en) | Dispenser for endermic administration of drug | |
| AU2002238748A1 (en) | Pharmaceutical aerosol formulation | |
| AU2001287930A1 (en) | Pharmaceutical formulation for pulmonary or nasal administration |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |